India Cements Position as World’s Leading Medical Tourism Destination in 2026

India continues to strengthen its position as the world’s leading destination for international patients in 2026, with the medical tourism sector projected to cross USD 13 billion this year. Patients from over 70 countries — particularly across Africa, the Middle East, Central Asia and South Asia — are travelling to India for everything from cardiac surgery and oncology to organ transplants and advanced procedures like CAR-T cell therapy.

What’s Driving the Growth?

• Cost advantage: Treatment in India typically costs 60–85% less than the USA or UK, even at top JCI / NABH accredited hospitals.
• Advanced procedures: HIPEC, Whipple’s procedure, robotic surgery, CyberKnife, Gamma Knife, DBS for Parkinson’s, CAR-T cell therapy — all widely available at top Indian centres.
• Minimal waiting time: Surgery typically within 7–14 days of arrival, vs months on NHS or insurance waiting lists.
• High-volume surgeons: Many Indian cardiac, oncology, and spine surgeons have 10,000+ procedure track records — well above international norms.
• English-language consultation and comprehensive international patient services at major hospitals.

Top Specialities for International Patients

The most-sought-after specialties for international patients coming to India in 2026 are:

• Cardiac surgery (CABG, valve replacement)
• Cancer surgery (HIPEC, Whipple, tumor resection)
• Neurosurgery and brain tumor surgery
• Spine surgery (scoliosis, disc replacement)
• Kidney transplant
• Bone marrow transplant
• Liver transplant
• Orthopaedics (joint replacement)
• IVF and reproductive medicine

Where Are the Patients Coming From?

The largest patient inflows to India in 2026 come from Nigeria, Kenya, Tanzania, Uganda, Ethiopia, Ghana, Rwanda, DR Congo, South Sudan (Africa); Yemen, Iraq, Oman, UAE (Middle East); Uzbekistan, Kazakhstan (Central Asia); and Bangladesh, Maldives (South Asia).